475207-59-1
MOSINTER
475207-59-1
Availability: | |
---|---|
Payment & Shipping Terms | Supply Capacity | ||
Payment Terms: | T/T, WU | Production Capacity: | 1000kg/year |
Min. Order: | 1 Gram | Packing: | according to the customer's requirements |
Means of Transport: | Ocean, Air, Land | Delivery Date: | 7 days |
Sorafenib Tosylate
CAS 475207-59-1
Sorafenib toluene sulfonate is a new multi-target anti-tumor drug, which was developed by Bayer pharmaceutical company in Germany. It can act on tumor cells and tumor blood vessels at the same time. It has dual antitumor effects: it can directly inhibit the proliferation of tumor cells by blocking the Raf / MEK / ERK mediated cell signaling pathway, and it can also block the formation of tumor neovascularization by inhibiting VEGF and PDGF receptor, and indirectly inhibit the growth of tumor cells.
We can customize according to customer's requirement
if you have any question pls mail us or call us.